Atıf Formatları
Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Turan, "Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart," International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , Timisoara, Romania, 2021

Turan, B. 2021. Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart. International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , (Timisoara, Romania).

Turan, B., (2021). Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart . International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , Timisoara, Romania

Turan, BELMA. "Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart," International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , Timisoara, Romania, 2021

Turan, BELMA. "Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart." International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , Timisoara, Romania, 2021

Turan, B. (2021) . "Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart." International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” , Timisoara, Romania.

@conferencepaper{conferencepaper, author={BELMA TURAN}, title={Mechanism of cardiovascular benefits of SGLT2 inhibitors in insulin-resistant mammal heart}, congress name={International Cooperation in Research - ”Pathophysiology at the Heart of Medicine” }, city={Timisoara}, country={Romania}, year={2021}}